
The NYLI Global Equity R&D Leaders ETF (WRND) aims to replicate the total return of the NYLI Global Equity R&D Leaders Index, before any deductions for fees or operating expenses. This underlying index focuses on identifying and investing in the stock of innovative, international companies that exhibit a consistent and proficient approach to their research and development (R&D) expenditures.
Is WRND's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Despite challenging economic backdrop, these global ETFs trumped the S&P 500 in the first nine months of 2023.

We have recently received three new ETFs built on the concept of R&D.

New York Life's ETF brand is targeting companies that spend big on research.

IndexIQ has expanded its ETF product lineup with the launch of three new equity-focused strategies. The new trio of funds — the IQ U.S. Large Cap R&D Leaders ETF (LRND), the IQ U.S. Mid Cap R&D Leaders ETF (MRND), and the IQ Global Equity R&D Leaders ETF (WRND) — launched on the NYSE on February 8.